Go Pro
→ A “bloodbath” Is Coming (From TradeSmith) (Ad)tc pixel Free IPHA Stock Alerts

Innate Pharma (IPHA) Stock Chart & Stock Price History

Innate Pharma logo
$2.22 -0.01 (-0.45%)
As of 04:00 PM Eastern
Compare

Innate Pharma Stock Price Performance

The Innate Pharma (IPHA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 6.22%, with a year-to-date return of 26.86%. In the past month, the stock has increased 23.33%, reflecting recent market activity.

As of the latest close, Innate Pharma traded at $2.22 with a market cap of $208.84 million and volume of 11,798 shares. Five years ago, the stock traded at $3.53, representing a 37.11% decrease over that period. At the time, it had a market cap of $279.45 million and a volume of 2,154 shares.

Receive IPHA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-1.77%
1 Month
Performance
+23.33%
3 Month
Performance
+27.59%
Year-To-Date
Performance
+26.86%
1 Year
Performance
+6.22%
5 Year
Performance
-37.11%

IPHA Stock Chart for Friday, August, 28, 2026

IPHA Chart by TradingView

Innate Pharma Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
08/28/2026$2.23$2.22
-0.45%		$2.29$2.2211,798 shs$208.84 million
08/27/2026$2.16$2.23
+3.24%		$2.26$2.226,057 shs$209.78 million
08/26/2026$2.27$2.16
-4.85%		$2.25$2.1620,469 shs$203.19 million
08/25/2026$2.20$2.27
+3.18%		$2.28$2.2127,970 shs$213.54 million
08/24/2026$2.26$2.20
-2.65%		$2.28$2.1858,942 shs$206.63 million
08/21/2026$2.09$2.26
+8.13%		$2.30$2.2044,354 shs$212.26 million
08/20/2026$2.12$2.09
-1.42%		$2.16$2.0552,438 shs$196.29 million
08/19/2026$2.07$2.12
+2.42%		$2.13$2.0927,072 shs$199.11 million
08/18/2026$2.26$2.07
-8.41%		$2.13$2.0446,130 shs$194.42 million
08/17/2026$2.18$2.26
+3.67%		$2.30$2.12217,231 shs$212.26 million
08/14/2026$2.54$2.18
-14.17%		$2.24$2.12105,784 shs$204.75 million
08/13/2026$2.47$2.54
+2.83%		$2.71$2.48192,582 shs$238.56 million
08/12/2026$2.15$2.47
+14.88%		$2.64$2.44384,884 shs$231.99 million
08/11/2026$2.22$2.15
-3.15%		$2.34$2.15439,449 shs$201.93 million
08/10/2026$1.73$2.22
+28.32%		$2.48$2.076.77 million shs$208.50 million
08/07/2026$1.79$1.73
-3.08%		$1.73$1.725,017 shs$162.48 million
08/06/2026$1.76$1.79
+1.71%		$1.79$1.603,334 shs$167.65 million
08/05/2026$1.79$1.76
-1.68%		$1.80$1.711,841 shs$164.83 million
08/04/2026$1.72$1.79
+3.78%		$1.81$1.752,338 shs$167.65 million
08/03/2026$1.75$1.72
-1.71%		$1.77$1.6947,280 shs$161.55 million
07/31/2026$1.75$1.75
+0.29%		$1.76$1.729,291 shs$164.36 million
07/30/2026$1.82$1.75
-4.12%		$1.77$1.7423,409 shs$163.89 million
07/29/2026$1.80$1.82
+1.11%		$1.84$1.82993 shs$170.93 million
07/28/2026$1.77$1.80
+1.58%		$1.91$1.685,182 shs$169.06 million
07/27/2026$1.78$1.77
-0.45%		$1.84$1.772,520 shs$166.43 million
Related Companies

This page (NASDAQ:IPHA) was last updated on 8/28/2026 by MarketBeat.com Staff.
From Our Partners
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
MILLIONAIRE MASTERCLASS INVITE: Altucher
James Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altuche...
Paradigm Press | Sponsoredtc pixel
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
Buy These Stocks Before August 31st
Keith Kaplan has invested $17 million into his own AI research platform, now used by 180,000 investors worldwi...
TradeSmith | Sponsoredtc pixel
Bank of America grew this stake 139%
Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, ...
Behind the Markets | Sponsoredtc pixel
I found Rolls-Royce at $2 - now I see the same setup again
In 2022, Karim Rahemtulla recommended Rolls-Royce under $2 - a misunderstood aerospace name the market had wri...
Monument Traders Alliance | Sponsoredtc pixel
How a schoolteacher turned $100 into $355,000
In 1903, a Detroit schoolteacher put $100 into a struggling carmaker named Ford, just as cheap gasoline met th...
Stansberry Research | Sponsoredtc pixel
A $382 trillion migration and the position no one is talking about
Trump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...
Awesomely | Sponsoredtc pixel